Rare Eosinophilic Diseases of High Clinical Burden - EGPA & HES: How Primary Care can Help Spot the Zebra
Industry Webcast Sponsored by GlaxoSmithKline; Not for CME/CE Credit
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly known as Churg-Strauss Syndrome, and hypereosinophilic syndrome (HES) are rare eosinophilic diseases of high consequence for patients, necessitating multi-specialty care. The prolonged patient journey and high clinical burden often entails repeat primary care provider (PCP) evaluation. This educational program will review key facets of the EGPA and HES disease states with a focus on the pivotal role PCPs can have to help shorten the patient journey to proper diagnosis and care.
This content is developed exclusively by or on behalf of the industry sponsor through a third party and is not reviewed by Pri-Med. The content and opinions expressed are those of the sponsor or presenters and may not reflect the views of Pri-Med.
Assistant Professor of Medicine
Adjunct Professor of Pediatrics, University of Utah Health,
Salt Lake City, Utah
This is a non-promotional, non-CME disease state educational program sponsored by GSK. Mili Shum, MD, and Neil Skolnik, MD are healthcare providers compensated by GSK.